ANTRAL HELICOBACTER-PYLORI-LIKE ORGANISMS IN DIFFERENT STATES OF GASTRIC-ACID SECRETION

被引:21
作者
KOOP, H [1 ]
STUMPF, M [1 ]
EISSELE, R [1 ]
LAMBERTS, R [1 ]
STOCKMANN, F [1 ]
CREUTZFELDT, W [1 ]
ARNOLD, R [1 ]
机构
[1] UNIV GOTTINGEN, DEPT MED, DIV GASTROENTEROL & ENDOCRINOL, W-3400 GOTTINGEN, GERMANY
关键词
DUODENAL ULCER; HELICOBACTER-PYLORI; GASTRINOMA; ESOPHAGITIS; OMEPRAZOLE; ZOLLINGER-ELLISON SYNDROME;
D O I
10.1159/000200698
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The frequency of Helicobacter pylori (H.p.) infestation in antral mucosa and the presence of gastritis were investigated in different states of gastric acid secretion. Biopsies were stained by the Warthin-Starry technique and hematoxylin-eosin. Antral H.p. was found in similar frequencies in Zollinger-Ellison syndrome (n = 17; profound acid hypersecretion, associated with duodenal ulcer disease in most cases) and the same number of age-matched controls (35% in each group) whereas H.p. could be detected in 31 out of 33 duodenal ulcer patients (94%). The incidence of H.p. infestation in H-2-blocker refractory reflux oesophagitis was low (24%). Treatment of peptic lesions with omeprazole (drug-induced hypochlorhydria) led to a reduction or disappearance of H.p. in 7 out of 10 H.p.-positive patients whereas none of 19 primarily H.p.-negative patients became infected with H.p. during prolonged omeprazole therapy. It is concluded that (1) development of duodenal ulcers (as in gastrinomas) does not necessarily require H.p., and (2) at least in some patients H.p. is reduced in antral mucosa by omeprazole.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 35 条
[1]   GASTRITIS AND CAMPYLOBACTER-PYLORI IN HEALTHY, ASYMPTOMATIC VOLUNTEERS [J].
BARTHEL, JS ;
WESTBLOM, TU ;
HAVEY, AD ;
GONZALEZ, F ;
EVERETT, ED .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (05) :1149-1151
[2]   OFLOXACIN IN THE TREATMENT OF CAMPYLOBACTER PYLORIPOSITIVE DUODENAL-ULCER - A PROSPECTIVE CONTROLLED RANDOMIZED TRIAL [J].
BAYERDORFFER, E ;
KASPER, G ;
PIRLET, T ;
SOMMER, A ;
OTTENJANN, R .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (37) :1407-1411
[3]  
BEHOLZ S, 1989, AM J GASTROENTEROL, V84, P201
[4]  
BIASCO G, 1989, LANCET, V2, P1403
[5]  
BORSCH G, 1988, EUR J CLIN INVEST, V18, P133
[6]   ACID-SECRETION AND SERUM GASTRIN-LEVELS IN INDIVIDUALS WITH CAMPYLOBACTER-PYLORI [J].
BRADY, CE ;
HADFIELD, TL ;
HYATT, JR ;
UTTS, SJ .
GASTROENTEROLOGY, 1988, 94 (04) :923-927
[7]  
CATALANO F, 1989, Z GASTROENTEROL, V27, P159
[8]   PREVALENCE OF CAMPYLOBACTER-PYLORI IN ESOPHAGITIS, GASTRITIS, AND DUODENAL DISEASE [J].
CHENG, EH ;
BERMANSKI, P ;
SILVERSMITH, M ;
VALENSTEIN, P ;
KAWANISHI, H .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (06) :1373-1375
[9]  
COGHLAN JG, 1987, LANCET, V2, P1109
[10]   LACK OF INVITRO ACTIVITY OF OMEPRAZOLE AGAINST CAMPYLOBACTER-PYLORI [J].
GHELANI, AM ;
HALE, S ;
COLEMAN, H ;
RADZIWONIK, H ;
ROBERTSON, C ;
ATKINSON, M .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (02) :171-172